YUMA THERAPEUTICS CORPORATION

Basic Information

1770 Massachusetts Avenue, Suite 170
Cambridge, MA, 02140-2808

Company Profile

n/a

Additional Details

Field Value
DUNS: 831491571
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: n/a


  1. CSF Tau Biomarker-guided Development of Hsp90 Inhibitors for Alzheimer's Disease

    Amount: $200,752.00

    DESCRIPTION (provided by applicant): Research and Related Other Project Information Item 7. Project Summary/Abstract Neurodegeneration in Alzheimer's disease (AD) may result from deposition of A ...

    STTR Phase I 2012 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government